|
| |
Protherics Medicines Development Pages on BioPortfolio:
Eden Biopharma Group raises £5million in investment
Biotech drug development and manufacturing service provider Eden Biopharma .... More recently he was Chief Scientific Officer of Protherics plc and is now ...
http://www.bioportfolio.com/news/Eden_Biopharm_1.htm...
|
Stakeholder Opinions: Novel Therapeutic Approaches in ...
The development timeline for stem cell technology 46 The exploitation of stem cells 47 Stem cell therapy 47 Use in regenerative medicine and tissue ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_409.html...
|
Dr John Brown joins SingVax Board as Chairman - Expanded Board ...
14 Aug 2006 ... Launched in May 2005, SingVax is a vaccine development company that ... Dr Lim has experience in clinical medicine and has been involved in ...
http://www.bioportfolio.com/biotech_news/SingVax_1.htm...
|
BioPortfolio - Proteus
Department of Medical Microbiology and Parasitology, College of Medicine, ... research and development,... www.protherics.co.uk/ View full profile ...
http://www.bioportfolio.com/indepth/Proteus.html...
|
PwC BioScience Index & Share League
exclusive development partnership on a human monoclonal antibody to TRAIL ... Alizyme has been granted regulatory permission from the UK Medicines Control ...
http://www.bioportfolio.com/pdf/Shareleague%20May-Jun%202002...
|
PwC BioScience Index & Share League
Phase III development as a treatment for Crohn's disease. GW Pharmaceuticals has commenced four new Phase III clinical trials of cannabis-based. medicines ...
http://www.bioportfolio.com/pdf/Shareleague%20Mar-Apr%202002...
|
Eli Lilly's Xigris: struggling to overcome its problems in the ...
28 Feb 2002 ... This development should help revive interest among hospital physicians, ... afelimomab and Protherics' CytoTAb target tumor necrosis factor. ...
http://www.bioportfolio.com/news/datamonitor_29.htm...
|
Biotechnology News CREST erk2. landreth. saitta. watanab. sulagna ...
A multidisciplinary research team at Case Western Reserve University led by Gary Landreth, Ph.D., a professor in the School of Medicine's Department of ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Biotechnology News Search
Protherics begins submission of rolling BLA for Voraxaze ... Aastrom Biosciences , Inc, a leading regenerative medicine company, announced that the first ...
http://www.bioportfolio.co.uk/Biotechnology_News_from_Pharma...
|
Biotechnology and Pharmaceutical Industry Search Find Companies ...
Mayo Clinic College of Medicine: similar . ... No more development for Pfizer's obesity compound ... Protherics PLC announces - Offer Update ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Results from other life science and pharmaceutical sites:
Non-linear enzymatic logic in natural product modular mega ...
Protherics Medicines Development and Advanced. In Vitro Cell Technologies jointly file application. covering an aminoimidazole derivative ...
http://www.biomedcentral.com/content/pdf/cd-854594.pdf...
|
US 7378489 B1 Angiotensin derivatives James Francis Glover ...
Assigned to Protherics Medicines Development Limited, Cheshire (United Kingdom). Filed on Dec. 23, 1999, as Appl. No. 9/470997. Int. Cl. C07K 7/14 (2006.01) ...
http://uspto.gov/web/patents/patog/week22/OG/html/1330-4/US0...
|
News: Protherics PLC announces Interim Results. Genetic ...
In addition, Protherics has several potential blockbuster products that require development and commercialisation partners. These include CytoFabTM which ...
http://www.genengnews.com/news/bnitem.aspx?name=45901964&tax...
|
It's Still the Blood Pressure -- But What About Diabetics?
A novel conjugate vaccine treatment for hypertension, in development with Protherics (Runcorn, United Kingdom) is in preclinical studies and is planned to
...
http://www.medscape.com/viewarticle/508565_8...
|
News: . Genetic Engineering & Biotechnology News - Biotechnology ...
... and Director of the Worm Institute of Research and Medicine, Scripps Research Institute . ... Vaccine Development Aided by New Techniques ...
http://www.genengnews.com/news/bnitem.aspx?name=45927073...
|
New Antihypertensive Therapies, and Old Hypertensive Risks?
17 Apr 2008 ... A similar antihypertensive vaccine under development by Protherics (London, UK, and Brentwood, Tennessee) is scheduled to be the focus of a ...
http://www.medscape.com/viewarticle/572933...
|
News: Protherics PLC announces Holding(s) in Company. Genetic ...
Nov 20, 2008 CHESHIRE, UK MARKET WIRE Protherics PLC Notification of Major ... of the Worm Institute of Research and Medicine, Scripps Research Institute . ...
http://www.genengnews.com/news/bnitem.aspx?name=45927929&tax...
|
Stakeholder Opinions: Novel Therapeutic Approaches in ...
The development timeline for stem cell technology 46 The exploitation of stem cells 47 Stem cell therapy 47 Use in regenerative medicine and tissue ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_409.html...
|
News: Protherics PLC announces Delisting from NASDAQ. Genetic ...
14 Nov 2008 ... In addition, Protherics has several potential blockbuster products that require development and commercialisation partners. ...
http://www.genengnews.com/news/bnitem.aspx?name=45515177...
|
John Patterson Pipeline overview script Thank you David and good ...
the field of cancer as well as increasing our ability to undertake clinical development and. accelerate our newer medicines into the Chinese market. ...
http://www.astrazeneca.com/sites/7/imagebank/typearticlepara...
|
|
